Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
3.18M
-
Number of holders
-
97
-
Total 13F shares, excl. options
-
42M
-
Shares change
-
-6.27M
-
Total reported value, excl. options
-
$130M
-
Value change
-
-$36.7M
-
Put/Call ratio
-
0
-
Number of buys
-
50
-
Number of sells
-
-45
-
Price
-
$3.10
Significant Holders of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) as of Q1 2022
118 filings reported holding PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share as of Q1 2022.
Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) has 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42M shares
.
Largest 10 shareholders include ORBIMED ADVISORS LLC (7.33M shares), Frazier Life Sciences Management, L.P. (5.01M shares), Versant Venture Management, LLC (4.96M shares), Deep Track Capital, LP (3.38M shares), BlackRock Inc. (3.29M shares), New Leaf Venture Partners, L.L.C. (2.5M shares), Woodline Partners LP (1.91M shares), VANGUARD GROUP INC (1.73M shares), HIGHLINE CAPITAL MANAGEMENT, L.P. (1.24M shares), and Erste Asset Management GmbH (1.02M shares).
This table shows the top 97 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.